BioAffinity Technologies Stock Forecast - Accumulation Distribution
| BIAF Stock | USD 1.30 0.05 3.70% |
BioAffinity Stock outlook is based on your current time horizon. We recommend always using this module together with an analysis of BioAffinity Technologies' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 27th of January 2026, the RSI of BioAffinity Technologies' share price is approaching 38 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling BioAffinity Technologies, making its price go up or down. Momentum 38
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (2.40) | EPS Estimate Current Year (14.40) | EPS Estimate Next Year (8.10) | Wall Street Target Price 6 | EPS Estimate Current Quarter (2.70) |
Using BioAffinity Technologies hype-based prediction, you can estimate the value of bioAffinity Technologies from the perspective of BioAffinity Technologies response to recently generated media hype and the effects of current headlines on its competitors.
BioAffinity Technologies after-hype prediction price | USD 1.33 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
BioAffinity | Build AI portfolio with BioAffinity Stock |
BioAffinity Technologies Additional Predictive Modules
Most predictive techniques to examine BioAffinity price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for BioAffinity using various technical indicators. When you analyze BioAffinity charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 2786.55 | 1446.93 |
| Check BioAffinity Technologies Volatility | Backtest BioAffinity Technologies | Information Ratio |
BioAffinity Technologies Trading Date Momentum
| On January 26 2026 bioAffinity Technologies was traded for 1.30 at the closing time. The top price for the day was 1.35 and the lowest listed price was 1.29 . The trading volume for the day was 32.6 K. The trading history from January 26, 2026 had no short-term effect on price fluctuation. The trading date delta against the current closing price is 3.85% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare BioAffinity Technologies to competition |
Other Forecasting Options for BioAffinity Technologies
For every potential investor in BioAffinity, whether a beginner or expert, BioAffinity Technologies' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. BioAffinity Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in BioAffinity. Basic forecasting techniques help filter out the noise by identifying BioAffinity Technologies' price trends.BioAffinity Technologies Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BioAffinity Technologies stock to make a market-neutral strategy. Peer analysis of BioAffinity Technologies could also be used in its relative valuation, which is a method of valuing BioAffinity Technologies by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
BioAffinity Technologies Market Strength Events
Market strength indicators help investors to evaluate how BioAffinity Technologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BioAffinity Technologies shares will generate the highest return on investment. By undertsting and applying BioAffinity Technologies stock market strength indicators, traders can identify bioAffinity Technologies entry and exit signals to maximize returns.
BioAffinity Technologies Risk Indicators
The analysis of BioAffinity Technologies' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in BioAffinity Technologies' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bioaffinity stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.91 | |||
| Standard Deviation | 5.07 | |||
| Variance | 25.75 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for BioAffinity Technologies
The number of cover stories for BioAffinity Technologies depends on current market conditions and BioAffinity Technologies' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that BioAffinity Technologies is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about BioAffinity Technologies' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
BioAffinity Technologies Short Properties
BioAffinity Technologies' future price predictability will typically decrease when BioAffinity Technologies' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of bioAffinity Technologies often depends not only on the future outlook of the potential BioAffinity Technologies' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BioAffinity Technologies' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 404.3 K | |
| Cash And Short Term Investments | 1.1 M |
Check out Historical Fundamental Analysis of BioAffinity Technologies to cross-verify your projections. For more detail on how to invest in BioAffinity Stock please use our How to Invest in BioAffinity Technologies guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioAffinity Technologies. If investors know BioAffinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioAffinity Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (13.83) | Revenue Per Share | Quarterly Revenue Growth (0.39) | Return On Assets | Return On Equity |
The market value of bioAffinity Technologies is measured differently than its book value, which is the value of BioAffinity that is recorded on the company's balance sheet. Investors also form their own opinion of BioAffinity Technologies' value that differs from its market value or its book value, called intrinsic value, which is BioAffinity Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioAffinity Technologies' market value can be influenced by many factors that don't directly affect BioAffinity Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioAffinity Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if BioAffinity Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioAffinity Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.